Biotech News

Valeant Pharmaceuticals International Inc., which is making a hostile takeover bid for Botox maker Allergan, posted a net profit of $126 million and saw its revenues jump.

Twitter and Amgen extended rallies in social media and biotechnology stocks since the U.S. central bank said two weeks ago that industry valuations are stretched.

Theraclone Sciences Inc. of Seattle said it's made a deal with Gilead Sciences Inc. that will allow the California company to develop and commercialize Theraclone's neutralizing HIV-antibodies for therapeutic applications in HIV.

After spending an estimated $16 million this fiscal year on Sovaldi, which holds promise for a cure for the liver-damaging disease, the state agency headed by Julie Hamos approved the restrictions July 10. The rules limit the drug to sicker patients and bar it for anyone with a history of drug or alcohol abuse within the past year.

You now have an easier online way to manage your Home Delivery subscription for The Oklahoman .

The S&P 500 was near flat on Wednesday after the Federal Reserve gave a rosier assessment of the U.S. economy while reaffirming that it is in no hurry to raise interest rates.

Humanitarian agencies working in west Africa on Wednesday stepped up their precautions against the Ebola virus, with the Peace Corps announcing it was removing hundreds of its volunteers from three of the hardest-hit nations.

Univ. of Washington bioengineers have discovered a potentially faster way to deliver a topical drug that protects women from contracting HIV.

In this Dec. 6, 2013 file photo, Sarah Davis, left, puts on earmuffs over her hat as John Davis, right, burrows under some blankets, as they try to keep warm in their tent at a homeless encampment in Oklahoma City.

A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.

DLA Piper announced today that Shane Albright has joined the firm's Corporate and Finance practice as a partner in the Silicon Valley office.

Sales for the second quarter of ... )--General Cable Corporation , announced today that its Board of Directors appointed Mr. Ned Hall to serve as an independent director of the Company ... )--Wellesley Bancorp, Inc. , the holding company for Wellesley Bank reported net income of $431 thousand an... )--The traditional subsidy model for wireless ... (more)

Biotechnology firm Amgen announced Tuesday that it plans to close its facilities in Colorado and Washington by the end of next year, resulting in the loss of approximately 430 jobs in Boulder County.

Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported very strong second-quarter results that trounced Wall Street expectations.

Drug firm Ranbaxy Laboratories today reported consolidated net loss of Rs 185.92 crore for the quarter ended June 30, 2014.

The potentially Ebola-related death last week of a Liberian government official whose wife and children live in Minnesota has heightened concerns and inspired a fundraising drive to send medical supplies to Liberia.

An outbreak of Ebola in West Africa may seem like a distant threat to many Americans, but it is causing some to cancel travel plans and stirring fear in Minnesota, which has the largest Liberian immigrant population in the United States.

Pfizer's second-quarter earnings plunged 79 per cent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion.

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.

In this Thursday, Feb. 28, 2013 photo, Merck scientist Pascale Nantermet conducts research to discover new HIV drugs in West Point, Pa.